Dementia. Alzheimer disease is a primary degenerative cerebral disease of unknown etiology with characteristic neuropathological and neurochemical features. The disorder is usually insidious in onset and develops slowly but steadily over a period of several years.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: First (direct) caregiver of the Dementia patient The age between 18-60. Reading and writing ability lack of cognitive impairments Ability to attending in the treatment sessions lack of physical problems affecting their mental state, Informed consent.
Exclusion criteria
Exclusion criteria: Participants should not require any medical treatment (i.e., pharmacological and non-pharmacological) between sessions Absence for more than two sessions Severe depression, psychosis, schizophrenia, bipolar disorder, or mental retardation Drug addiction. ( that will be verified by the information available in the case file and interview)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in scores anxiety. Timepoint: Before intervention,after intervention ,after 3 month. Method of measurement: Questionnaire.;Change in score of depression. Timepoint: Before intervention,after intervention ,after 3 month. Method of measurement: Questionnaire.;Change in quality of life. Timepoint: Before intervention,after intervention ,after 3 month. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences